Vice President, Global Strategy
- Kevin Hurley
Mr. Hurley brings extensive regulatory expertise from his experience in pharmaceutical and biotech companies and technical and consulting roles.
- Dr. Kelly McKee, MD, MPH
In both his current role in the pharmaceutical industry and previous role as a research virologist and immunologist in the United States Army, Dr. McKee developed expertise that spans vaccines, respiratory viral infections, emerging diseases and sexually transmitted diseases.
- Dr. John Schieffelin, MD, MSPH
Dr. Schieffelin’s scientific and clinical research has covered the natural history, clinical care and immunology of viral hemorrhagic fevers, including those caused by flaviviruses, such as dengue and Zika, as well as Lassa fever and Ebola.
- Dr. Lucas Tina, MBChB, MSc
Dr. Tina’s experience spans successful drug and vaccine trials for neglected diseases and emerging infectious diseases, including malaria and polio.
- Dr. Stacey Wooden, PhD, MPH
Stacey Wooden is a vaccine immunologist and global health researcher with over 25 years of experience in infectious disease research.
- Dr. Christopher T. Woods, MD, MPH, FIDSA
Dr. Woods’s career has focused on epidemiology, genomics and precision medicine in infectious diseases.
